Analytical Data
-
Gene name
MAP3K7CL
- Application
-
Alternative Names
TAK1-like protein
-
Species
Human
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P57077
-
Expression Region
1-142aa
-
Molecular Weight
32.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MAP3K7CL, a member of the mitogen-activated protein kinase (MAPK) signaling pathway, has garnered significant attention in recent years due to its crucial role in various cellular processes, including proliferation, differentiation, and apoptosis. Characterized as a kinase that interacts with multiple signaling cascades, MAP3K7CL is involved in the activation of downstream effectors that modulate immune responses and developmental processes. Its functionality has been implicated in several diseases, particularly cancer and neurodegenerative disorders, making it a potential therapeutic target. Moreover, the study of recombinant MAP3K7CL proteins allows for a deeper understanding of their structural and functional properties, facilitating the exploration of their interaction dynamics with other proteins in signaling networks. By utilizing advanced techniques such as protein engineering and structural biology, researchers aim to unravel the regulatory mechanisms governing MAP3K7CL activity. Investigating these recombinantly expressed proteins can also provide insights into post-translational modifications and their implications for cellular signaling. Overall, the research surrounding MAP3K7CL recombinant proteins is essential for elucidating the complexities of MAPK signaling pathways and for developing targeted therapies to combat diseases associated with dysregulation of these pathways.
